Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Neurobiology of Disease|May 5, 2022
Evidence for immune system alterations in peripheral biological fluids in Parkinson's diseaseMichael Bartl, Mary Xylaki, Mathias Bähr, et al.Movement Disorders : Official Journal of the Movement Disorder Society|July 14, 2023
Extracellular Vesicles for the Diagnosis of Parkinson's Disease: Systematic Review and Meta-AnalysisMary Xylaki, Avika Chopra, Sandrina Weber, et al.Journal of Parkinson'S Disease|November 1, 2021
Longitudinal Change and Progression Indicators Using the Movement Disorder Society-Unified Parkinson's Disease Rating Scale in Two Independent Cohorts with Early Parkinson's DiseaseMichael Bartl, Mohammed Dakna, Sebastian Schade, et al.Gene|March 19, 2020
A novel pathogenic variant in MYO18B associating early-onset muscular hypotonia, and characteristic dysmorphic features, delineation of the phenotypic spectrum of MYO18B-related conditionsTheresa Brunet, Dominik S Westphal, Sandrina Weber, et al.Movement Disorders : Official Journal of the Movement Disorder Society|April 9, 2025
Anosmia and Upper Limb Rigidity-A Potential Phenotype of Idiopathic Normal Pressure Hydrocephalus with Cerebrospinal Fluid α-Synuclein SeedsSandrina Weber, Carly M Farris, Yihua Ma, et al.International Journal of Molecular Sciences|December 11, 2025
Proteomic Exploration of L1CAM+-Extracellular Vesicles from Plasma of Manifest and Prodromal Parkinson's DiseaseMary Xylaki, Avika Chopra, Yevheniia Kyriachenko, et al.Cold Spring Harbor Molecular Case Studies|September 29, 2018
A unique de novo gain-of-function variant in CAMK4 associated with intellectual disability and hyperkinetic movement disorderMichael Zech, Daniel D Lam, Sandrina Weber, et al.Parkinsonism & Related Disorders|August 2, 2016
Systematic TOR1A non-c.907_909delGAG variant analysis in isolated dystonia and controlsMichael Zech, Angela Jochim, Sylvia Boesch, et al.Movement Disorders : Official Journal of the Movement Disorder Society|October 21, 2022
Blood Markers of Inflammation, Neurodegeneration, and Cardiovascular Risk in Early Parkinson's DiseaseMichael Bartl, Mohammed Dakna, Sebastian Schade, et al.NPJ Parkinson'S Disease|May 17, 2024
Lysosomal and synaptic dysfunction markers in longitudinal cerebrospinal fluid of de novo Parkinson's diseaseMichael Bartl, Johanna Nilsson, Mohammed Dakna, et al.Pageof 3